BMY - RT

torpedoswap said:
I saw $4.40 pre-market :)
More...
Looks like your doubling down at ~$2 a couple of weeks ago is paying off big time. BMY-RT is trading @$4.23 right now.

Of the three drugs in clinical trial, one already approved by the FDA, two are in process and the chances of all three approved by March 2021 are quite promising.
 
Yes, I sold everything last week. It could run further up, but I am not going to complain with ~60% profit. Hopefully I can get back in on the next dip. Rigged market with the FED intervention is driving me nuts ..... feel like I have been left watching with dry powder in my hands. Fingers crossed and patiently waiting!
 
torpedoswap said:
Yes, I sold everything last week. It could run further up, but I am not going to complain with ~60% profit. Hopefully I can get back in on the next dip. Rigged market with the FED intervention is driving me nuts ..... feel like I have been left watching with dry powder in my hands. Fingers crossed and patiently waiting!
More...
:thumbsup::thumbsup::thumbsup: Hard to complain when you made 60% in a few months.

You are probably doing the right thing. In this pandemic, the FDA will not have time to act on anything other than COVID-19 related so there are significant schedule risks. Me, I am going to hang in there a little longer but I am ready to sell at any sign of schedule slips.

Take care.
 
It is going up on low volume and until $5 it makes sense fundamentally, so I think you are doing good.

Its up 60 cents from the point I sold .... oh good old hind sight! :)
 
Going down on high volume, what happened?
Liso-cell submission extension by FDA affecting this?

I think I will get back in half position if it dips below $3.5 today & add more if they push it below $3 later. I don't think much has changed fundamentally.
 
torpedoswap said:
Going down on high volume, what happened?
Liso-cell submission extension by FDA affecting this?

I think I will get back in half position if it dips below $3.5 today & add more if they push it below $3 later. I don't think much has changed fundamentally.
More...
FDA ruling/approval expected mid Nov 2020. The reason for the delay was FDA considered their modified response material and wanted more time to examine. Since it is all or nothing on this drug by year end 2020 folks were nervous and all tried to get out.

Didn't quite get down to $3.5. I bought some more at $3.9. :vomit:
 
I just got back in .... although the FDA rejection does hurt the success probability. Not sure if it dipped below 2 pre-market but if it does again, I will double down. I am less confident on this than before though. Lets see how things work out, fingers crossed!
 
You must log in or register to reply here.
Back
Top